As clinical diagnostics become a central force in shaping therapies and driving innovation, healthcare leaders must prepare ...

SAN DIEGO, December 17, 2025--(BUSINESS WIRE)--SOLVD Health, a patient intelligence company pioneering precision medicine through advanced genetics and AI-driven insights, announced today that its ...

SOLVD Health, a patient intelligence company pioneering precision medicine through advanced genetics and AI-driven insights, announced today that its pharmacogenomics (PGx) test PreScript™ has ...

Following the successful completion of the NHS national pilot in April 2025, the highly anticipated first results assessing CYP2C19 genetic testing to guide clopidogrel use in ischaemic stroke and TIA ...

Lenovo CES 2026 leak reveals smart AI glasses, a personal AI hub, and adaptive displays that rethink how AI fits into ...

Proof-of-concept devices unveiled in Las Vegas last week showed that the era of innovation in form factors is not over, ...

Lenovo often uses trade shows to announce a slew of proof-of-concept announcements, and CES 2026 brings two rollable displays ...

Stories about federal funding cuts, lab test regulation, and increasing adoption of DPYD testing were the most popular among readers.

Below is a list of the 10 precision oncology stories that resonated most with readers during the year: 2. Mass General Brigham Becomes Latest US Health System to Adopt Pretreatment DPYD Testing 3. JP ...

Lenovo is getting creative at CES 2026, showing off a handful of concept devices that could change the way we think about ...

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

Invesco Preferred ETF (PGX) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.